Your browser doesn't support javascript.
loading
Perniosis in the COVID-19 era.
Shah, Ishan; Stacey, Stephen K; Ganne, Nandita; Merfeld, John.
Afiliação
  • Shah I; Family Medicine Residency Program, Mayo Clinic Health System, La Crosse, WI. shah.ishan@mayo.edu.
Dermatol Online J ; 27(5)2021 May 15.
Article em En | MEDLINE | ID: mdl-34118825
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and the most common symptoms include fever, dry cough, dyspnea, fatigue, anorexia, ageusia, and anosmia. Cutaneous manifestations are less common and we share our experience with an otherwise healthy and asymptomatic young man. The patient presented with painless acrocynosis of the left toes which progressed to desquamation by day 16 of disease onset. Disease progression is documented via multiple photographs that portray progression of disease and subsequent resolution over approximately six weeks. Symptomatic treatment included non-steroidal anti-inflammatory medications, leg elevation, and warm compresses.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pérnio / Dermatoses do Pé / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pérnio / Dermatoses do Pé / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article